Cited by 1,709Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacySynthesis of β-Lactam Compounds

The DOI matches its Crossref record; 462 of the 464 references it cites were found in a registry or an index.

Three Decades of β-Lactamase Inhibitors

Open access

Drawz, Sarah M., Bonomo, Robert A.·2010·Clinical Microbiology Reviews

Open this paper in CoChat — free account

Abstract

Since the introduction of penicillin, beta-lactam antibiotics have been the antimicrobial agents of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by bacterial beta-lactamases. beta-Lactamases are now responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. In order to overcome beta-lactamase-mediated resistance, beta-lactamase inhibitors (clavulanate, sulbactam, and tazobactam) were introduced into clinical practice. These inhibitors greatly enhance the efficacy of their partner beta-lactams (amoxicillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Enterobacteriaceae and penicillin-resistant staphylococcal infections. However, selective pressure from excess antibiotic use accelerated the emergence of resistance to beta-lactam-beta-lactamase inhibitor combinations. Furthermore, the prevalence of clinically relevant beta-lactamases from other classes that are resistant to inhibition is rapidly increasing. There is an urgent need for effective inhibitors that can restore the activity of beta-lactams. Here, we review the catalytic mechanisms of each beta-lactamase class. We then discuss approaches for circumventing beta-lactamase-mediated resistance, including properties and characteristics of mechanism-based inactivators. We next highlight the mechanisms of action and salient clinical and microbiological features of beta-lactamase inhibitors. We also emphasize their therapeutic applications. We close by focusing on novel compounds and the chemical features of these agents that may contribute to a "second generation" of inhibitors. The goal for the next 3 decades will be to design inhibitors that will be effective for more than a single class of beta-lactamases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00037-09

Cites

462 of 462 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Self-citation
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,646
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,485
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,328
AmpC β-Lactamases
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,619
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542

Show all 464 references

Research works printed but not linked: 14

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.
Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.
Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.
A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009
Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.
Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.
F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

Sorted by citations

Items 501–600 of 1,001

The Antistaphylococcal Activity of Amoxicillin/Clavulanic Acid, Gentamicin, and 1,8‐Cineole Alone or in Combination and Their Efficacy through a Rabbit Model of Methicillin‐Resistant Staphylococcus aureus Osteomyelitis
Hriouech, S., Akhmouch, A. A., Mzabi, A., Chefchaou, H., Tanghort, M., Oumokhtar, B., Chami, N., & Remmal, A. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4271017 · Cited by 34
Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli
Lang, P. A., Parkova, A., Leissing, T. M., Calvopiña, K., Cain, R. M., Krajnc, A., Panduwawala, T., Philippe, J., Fishwick, C. W. G., Trapencieris, P., et al. (2020) · Biomolecules · doi:10.3390/biom10060899 · Cited by 34
Allosteric inhibition of VIM metallo-β-lactamases by a camelid nanobody
Sohier, J., Laurent, C., Chevigné, A., Pardon, E., Srinivasan, V., Wernery, U., Lassaux, P., Steyaert, J., & Galleni, M. (2013) · Biochemical Journal · doi:10.1042/bj20121305 · Cited by 34
Crystal Structure of a Complex between the Actinomadura R39 dd -Peptidase and a Peptidoglycan-mimetic Boronate Inhibitor: Interpretation of a Transition State Analogue in Terms of Catalytic Mechanism
Dzhekieva, L., Rocaboy, M., Kerff, F., Charlier, P., Sauvage, E., & Pratt, R. F. (2010) · Biochemistry · doi:10.1021/bi100757c · Cited by 34
Evidence of Adaptability in Metal Coordination Geometry and Active-Site Loop Conformation among B1 Metallo-β-lactamases,
González, J. M., Buschiazzo, A., & Vila, A. J. (2010) · Biochemistry · doi:10.1021/bi100894r · Cited by 34
The Class D β-lactamase family: residues governing the maintenance and diversity of function
Szarecka, A., Lesnock, K. R., Ramirez-Mondragon, C. A., Nicholas, H. B., & Wymore, T. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr041 · Cited by 34
Asymmetric Synthesis of Spiro β‐Lactams via a Squaramide‐ Catalyzed Sulfa‐Michael Addition/Desymmetrization Protocol
Chauhan, P., Mahajan, S., Kaya, U., Valkonen, A., Rissanen, K. T., & Enders, D. (2016) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201600554 · Cited by 34
Cranberry-Derived Proanthocyanidins Potentiate β-Lactam Antibiotics against Resistant Bacteria
Gallique, M., Wei, K., Maisuria, V. B., Okshevsky, M., McKay, G. A., Nguyen, D. M., & Tufenkji, N. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.00127-21 · Cited by 33
Ceftazidime–avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections
Mawal, Y. R., Critchley, I. A., Riccobene, T. A., & Talley, A. K. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1090874 · Cited by 33
To the rescue of old drugs
Meziane‐Cherif, D., & Courvalin, P. M. (2014) · Nature · doi:10.1038/510477a · Cited by 33
Metallo-β-Lactamases: Structural Features, Antibiotic Recognition, Inhibition, and Inhibitor Design
Wang, J., & Chou, K. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990011 · Cited by 33
Solution structures of the Bacillus cereus metallo-β-lactamase BcII and its complex with the broad spectrum inhibitor R-thiomandelic acid
Karsisiotis, A. I., Damblon, C., & Roberts, G. C. K. (2013) · Biochemical Journal · doi:10.1042/bj20131003 · Cited by 33
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening
Lund, B. A., Christopeit, T., Guttormsen, Y., Bayer, A., & Leiros, H. S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00660 · Cited by 33
Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus
Vermote, A., & Calenbergh, S. V. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00084 · Cited by 34
A quinoline-based FtsZ inhibitor for the study of antimicrobial activity and synergistic effects with β-lactam antibiotics
Fang, Z., Ban, L., Li, Y., Yuan, W., Liu, Z., Liu, T., Li, X., Wong, K., Lu, Y., Sun, N., et al. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.07.005 · Cited by 33
Temporal association between antibiotic use and resistance in Klebsiella pneumoniae at a tertiary care hospital
Ryu, S., Klein, E. Y., & Chun, B. C. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0373-6 · Cited by 33
Dithiocarbamates: Efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem
Wang, M., Chu, W.-C., Yang, Y., Yang, Q., Qin, S., & Zhang, E. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.028 · Cited by 33
Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates
Cahill, S. T., Tyrrell, J. M., Navratilova, I. H., Calvopiña, K., Robinson, S. W., Lohans, C. T., McDonough, M. A., Cain, R. M., Fishwick, C. W. G., Avison, M. B., et al. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.02.004 · Cited by 33
Precise Cas9 targeting enables genomic mutation prevention
Chavez, A., Pruitt, B. W., Tuttle, M. L., Shapiro, R. S., Cecchi, R. J., Winston, J., Turczyk, B. M., Tung, M., Collins, J. J., & Church, G. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718148115 · Cited by 32
Conformational Dynamics of the Helix 10 Region as an Allosteric Site in Class A β-Lactamase Inhibitory Binding
Huang, L., So, P., Chen, Y. W., Leung, Y., & Yao, Z. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c04088 · Cited by 33
Isolation of antibiotic-resistant bacteria in biogas digestate and their susceptibility to antibiotics
Sun, H., Bjerketorp, J., Levenfors, J. J., & Schnürer, A. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115265 · Cited by 32
Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors
Shaaban, M. M., Ragab, H. M., Akaji, K., McGeary, R. P., Bekhit, A. E. A., Hussein, W. M., Kurz, J. L., Elwakil, B. H., Bekhit, S. A., Ibrahim, T. M., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104386 · Cited by 33
New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases
Yang, K., Feng, L., Yang, S.-K., Aitha, M., LaCuran, A. E., Oelschlaeger, P., & Crowder, M. W. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.098 · Cited by 33
Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of β-lactams
Price, N. P. J., Hartman, T. M., Li, J., Velpula, K. K., Naumann, T. A., Guda, M. R., Yu, B., & Bischoff, K. M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.101 · Cited by 33
Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo
Su, J.-P., Liu, J., Chen, C., Zhang, Y., & Yang, K. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.035 · Cited by 33
Reviewing novel treatment options for carbapenem-resistant Enterobacterales
Mackow, N., & van Duin, D. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2303028 · Cited by 32
Rational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site Residues
Otrubova, K., Brown, M. A., McCormick, M. S., Han, G. W., O’Neal, S. T., Cravatt, B. F., Stevens, R. C., Lichtman, A. H., & Boger, D. L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4014997 · Cited by 32
Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase
Fako, V. E., Zhang, J., & Liu, J. (2014) · ACS Catalysis · doi:10.1021/cs500956m · Cited by 32
Following Drug Uptake and Reactions inside Escherichia coli Cells by Raman Microspectroscopy
Heidari‐Torkabadi, H., Bethel, C. R., Papp‐Wallace, K. M., de Boer, P. A. J., Bonomo, R. A., & CAREY, P. R. (2014) · Biochemistry · doi:10.1021/bi500529c · Cited by 32
Self-citation
Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition
Li, G., Brem, J., Leśniak, R. K., Abboud, M. I., Lohans, C. T., Clifton, I. J., Yang, S., Jiménez-Castellanos, J.-C., Avison, M. B., SPENCER, J. M., et al. (2017) · Chemical Communications · doi:10.1039/c7cc02394d · Cited by 32
Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches
van den Akker, F., & Bonomo, R. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00622 · Cited by 32
Self-citation
Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor
Lui, H. K., Gao, W., Cheung, K. C., Jin, W., Sun, N., Kan, J. W. Y., Wong, I. L. K., Chiou, J. A., Lin, D., Chan, E. W., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.052 · Cited by 32
The role of new β-lactamase inhibitors in gram-negative infections
Vena, A., Castaldo, N., & Bassetti, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000600 · Cited by 32
An African perspective on the prevalence, fate and effects of carbapenem resistance genes in hospital effluents and wastewater treatment plant (WWTP) final effluents: A critical review
Ebomah, K. E., & Okoh, A. I. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03899 · Cited by 36
Mitochondrial Proteostasis Requires Genes Encoded in a Neurodevelopmental Syndrome Locus
Gokhale, A., Lee, C. E., Zlatic, S. A., Freeman, A. A. H., Shearing, N., Hartwig, C. L., Ogunbona, O. B., Bassell‐Hawkins, J., Wynne, M. E., Werner, E., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2197-20.2021 · Cited by 30
Mutant Prevention Concentrations of Four Carbapenems against Gram-Negative Rods
Credito, K. L., Kosowska-Shick, K., & Appelbaum, P. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00033-10 · Cited by 32
An Extensive Review on β-lactamase Enzymes and their Inhibitors
Agarwal, V., Tiwari, A., & Varadwaj, P. K. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220620165429 · Cited by 31
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities
Martinelli, F., & Thiele, I. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387400 · Cited by 33
Data-Driven Approaches in Antimicrobial Resistance: Machine Learning Solutions
Sakagianni, A., Koufopoulou, C., Koufopoulos, P., Kalantzi, S., Theodorakis, N., Nikolaou, M., Paxinou, E., Kalles, D., Verykios, V. S., Myrianthefs, P. M., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13111052 · Cited by 37
New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis
Tassoni, R., Blok, A. J., Pannu, N. S., & Ubbink, M. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01085 · Cited by 31
Comparative Genomics and Metabolomics Analyses of Clavulanic Acid-Producing Streptomyces Species Provides Insight Into Specialized Metabolism
AbuSara, N. F., Piercey, B. M., Moore, M. A., Shaikh, A. A., Nothias-Scaglia, L.-F., Srivastava, S. K., Cruz‐Morales, P., Dorrestein, P. C., Barona‐Gómez, F., & Tahlan, K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02550 · Cited by 30
3-Bromopyruvate as a potent covalently reversible inhibitor of New Delhi metallo-β-lactamase-1 (NDM-1)
Kang, P.-W., Su, J.-P., Sun, L.-Y., Gao, H., & Yang, K. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105161 · Cited by 31
Bioisosteric investigation of ebselen: Synthesis and in vitro characterization of 1,2-benzisothiazol-3(2H)-one derivatives as potent New Delhi metallo-β-lactamase inhibitors
Jin, W., Xu, C., Cheung, Q., Gao, W., Zeng, P., Liu, J., Chan, E. W., Leung, Y., Chan, T. H., Wong, K., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103873 · Cited by 31
A turn-on fluorescent aptasensor for ampicillin detection based on gold nanoparticles and CdTe QDs
Yu, W., Hao, A., Mei, Y., Yang, Y., & Dai, C. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107454 · Cited by 31
A β‐Lactamase‐Imprinted Responsive Hydrogel for the Treatment of Antibiotic‐Resistant Bacteria
Li, W., Dong, K., Ren, J., & Qu, X. (2016) · Angewandte Chemie · doi:10.1002/ange.201600205 · Cited by 31
Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination ofβ-Lactam Resistance Genes among the Enterobacteriaceae
Adamczuk, M., Zaleski, P., Dziewit, Ł., Wolinowska, R., Nieckarz, M., Wawrzyniak, P., Kierył, P., Płucienniczak, A., & Bartosik, D. (2015) · BioMed Research International · doi:10.1155/2015/414681 · Cited by 31
Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia
Chouchani, C., Marrakchi, R., & Salabi, A. A. E. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.552880 · Cited by 31
Novel Insights into the Mode of Inhibition of Class A SHV-1 β-Lactamases Revealed by Boronic Acid Transition State Inhibitors
Ke, W., Sampson, J. M., Ori, C., Prati, F., Drawz, S. M., Bethel, C. R., Bonomo, R. A., & van den Akker, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00930-10 · Cited by 31
Self-citation
Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition
Choi, H., Paton, R. S., Park, H., & Schofield, C. J. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00353b · Cited by 34
Production of β-Lactamase Inhibitors by Streptomyces Species
Marques, D. D. A. V., Machado, S. E. F., Santos‐Ebinuma, V. C., Duarte, C. D. A. L., Converti, A., & Porto, A. L. F. (2018) · Antibiotics · doi:10.3390/antibiotics7030061 · Cited by 79
Antimicrobial potential and rhodamine B dye degradation using graphitic carbon nitride and polyvinylpyrrolidone doped bismuth tungstate supported with in silico molecular docking studies
Ashfaq, M. H., Imran, M., Haider, A., Shahzadi, A., Mustajab, M., Ul‐Hamid, A., Nabgan, W., Medina, F., & Ikram, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-44799-9 · Cited by 30
A systematic overview of strategies for photosensitizer and light delivery in antibacterial photodynamic therapy for lung infections
Shleeva, M. O., Demina, G. R., & Savitsky, A. P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115472 · Cited by 32
Inactivation of TEM-1 by Avibactam (NXL-104): Insights from Quantum Mechanics/Molecular Mechanics Metadynamics Simulations
Sgrignani, J., Grazioso, G., Amici, M. D., & Colombo, G. (2014) · Biochemistry · doi:10.1021/bi500589x · Cited by 30
Regio- and Diastereoselective Synthesis of β-Lactam-Triazole Hybrids via Passerini/CuAAC Sequence
Alcaide, B., Almendros, P., Aragoncillo, C., Callejo, R., Ruiz, M. P., & Torres, M. R. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo301113g · Cited by 30
Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
Lee, D., Das, S., Dawson, N. L., Dobrijevic, D., Ward, J. M., & Orengo, C. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004926 · Cited by 30
Substrate Binding Induces Conformational Changes in a Class A β-lactamase That Prime It for Catalysis
Langan, P. S., Vandavasi, V. G., Cooper, C. J., Weiss, K. L., Ginell, S. L., Parks, J. M., & Coates, L. (2018) · ACS Catalysis · doi:10.1021/acscatal.7b04114 · Cited by 30
Staphylococcus aureus in tonsils of patients with recurrent tonsillitis: prevalence, susceptibility profile, and genotypic characterization
Cavalcanti, V. P., de Camargo, L. A., Moura, F. S., Fernandes, E. J. D. M., Lamaro‐Cardoso, J., Braga, C. A. D. S. B., & André, M. C. P. (2019) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.12.003 · Cited by 33
Beta-lactam resistance in Campylobacter coli and Campylobacter jejuni chicken isolates and the association between blaOXA-61 gene expression and the action of β-lactamase inhibitors
Proietti, P. C., Guelfi, G., Bellucci, S., Luca, S. D., Gregorio, S. D., Pieramati, C., & Franciosini, M. P. (2019) · Veterinary Microbiology · doi:10.1016/j.vetmic.2019.108553 · Cited by 30
Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid
Suzuki, E., Nakai, D., Yamamura, N., Kobayashi, N., Okazaki, O., & Izumi, T. (2011) · Xenobiotica · doi:10.3109/00498254.2011.596582 · Cited by 30
A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii
Marie, M. A. M., Krishnappa, L. G., Alzahrani, A. J., Mubaraki, M. A., & Alyousef, A. A. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.526 · Cited by 30
Tetracyclic indolines as a novel class of β-lactam-selective resistance-modifying agent for MRSA
Zhu, Y., Cleaver, L., Wang, W., Podoll, J. D., Walls, S., Jolly, A., & Wang, X. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.034 · Cited by 30
The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation
Patel, M. P., Hu, L., Stojanoski, V., Sankaran, B., Prasad, B. V. V., & Palzkill, T. G. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00176 · Cited by 30
Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
Atkin, S. D., Abid, S., Foster, M., Bose, M., Keller, A. E., Hollaway, R., Sader, H. S., Greenberg, D. E., Finklea, J. D., Castanheira, M., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173804 · Cited by 30
A catalase–peroxidase for oxidation of β-lactams to their (R)-sulfoxides
Sangar, S., Pal, M., Moon, L. S., & Jolly, R. S. (2011) · Bioresource Technology · doi:10.1016/j.biortech.2011.09.045 · Cited by 30
QM/MM Simulations Reveal the Determinants of Carbapenemase Activity in Class A β-Lactamases
Chudyk, E. I., Beer, M., Limb, M. A. L., Jones, C., SPENCER, J. M., van der Kamp, M. W., & Mulholland, A. J. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00152 · Cited by 29
Emerging Applications of Aggregation‐Induced Emission Luminogens in Bacterial Biofilm Imaging and Antibiofilm Theranostics
Liu, P., Li, D., Kang, M., Pan, Y., Wen, Z., Zhang, Z., Wang, D., & Tang, B. Z. (2023) · Small Structures · doi:10.1002/sstr.202200329 · Cited by 30
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
Everaert, A., & Coenye, T. (2016) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-016-0142-3 · Cited by 29
Bacterial zincophore [S,S]-ethylenediamine-N,N′-disuccinic acid is an effective inhibitor of MBLs
Proschak, A., Kramer, J. S., Proschak, E., & Wichelhaus, T. A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx403 · Cited by 29
Synergistic antibacterial mechanism of Bi2Te3 nanoparticles combined with the ineffective β-lactam antibiotic cefotaxime against methicillin-resistant Staphylococcus aureus
Liu, X., Ma, L., Chen, F., Liu, J., Yang, H., & Lu, Z. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.04.001 · Cited by 29
Ribosome Protection Proteins—“New” Players in the Global Arms Race with Antibiotic-Resistant Pathogens
Ero, R., Yan, X., & Gao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105356 · Cited by 30
The Different Inhibition Mechanisms of OXA-1 and OXA-24 β-Lactamases Are Determined by the Stability of Active Site Carboxylated Lysine
Che, T., Bethel, C. R., Pusztai‐Carey, M., Bonomo, R. A., & CAREY, P. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533562 · Cited by 29
Self-citation
The Antibiotic Resistome: Challenge And Opportunity For Therapeutic Intervention
Martínez, J. L. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.2 · Cited by 29
A fluorogenic substrate of beta-lactamases and its potential as a probe to detect the bacteria resistant to the third-generation oxyimino-cephalosporins
Thai, H. B. D., Yu, J. K., Park, B. S., Park, Y.-J., Min, S., & Ahn, D. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.10.081 · Cited by 29
Mapping Conformational Dynamics to Individual Steps in the TEM-1 β-Lactamase Catalytic Mechanism
Knox, R., Lento, C., & Wilson, D. J. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.045 · Cited by 29
Iminodiacetic Acid as a Novel Metal‐Binding Pharmacophore for New Delhi Metallo‐β‐lactamase Inhibitor Development
Chen, A. Y., Thomas, C. A., Thomas, P. W., Yang, K., Cheng, Z., Fast, W. L., Crowder, M. W., & Cohen, S. M. (2020) · ChemMedChem · doi:10.1002/cmdc.202000123 · Cited by 29
Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery
Torelli, N. J., Akhtar, A., DeFrees, K., Jaishankar, P., Pemberton, O. A., Zhang, X., Johnson, C., Renslo, A. R., & Chen, Y. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00052 · Cited by 29
A chromogenic cephalosporin for β-lactamase inhibitor screening assays
Yu, S., Vosbeek, A., Corbella, K., Severson, J., Schesser, J., & Sutton, L. D. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.06.006 · Cited by 29
In Vitro Antistaphylococcal Synergistic Effect of Isoflavone Metabolite Demethyltexasin with Amoxicillin and Oxacillin
Rondevaldová, J., Hummelova, J., Tauchen, J., & Kokoška, L. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0033 · Cited by 28
A DNA aptamer reveals an allosteric site for inhibition in metallo-β-lactamases
Khan, N. H., Bui, A. A., Xiao, Y., Sutton, R. B., Shaw, R. W., Wylie, B. J., & Latham, M. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214440 · Cited by 28
Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis
Sonnabend, M., Klein, K., Beier, S., Angelov, A., Kluj, R. M., Mayer, C., Groß, C., Hofmeister, K., Beuttner, A., Willmann, M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01771-19 · Cited by 28
New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae
Brennan-Krohn, T., Manetsch, R., O'Doherty, G. A., & Kirby, J. E. (2020) · Translational research · doi:10.1016/j.trsl.2020.02.008 · Cited by 28
Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics
Egorov, A. M., Ulyashova, M. M., & Rubtsova, M. Y. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920110024 · Cited by 28
Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli
Becka, S. A., Zeiser, E. T., LiPuma, J. J., & Papp‐Wallace, K. M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01332-21 · Cited by 28
QM/MM Study of a VIM-1 Metallo-β-Lactamase Enzyme: The Catalytic Reaction Mechanism
Medina, F. E., & Jaña, G. A. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c04786 · Cited by 28
A novel combination therapy for multidrug resistant pathogens using chitosan nanoparticles loaded with β-lactam antibiotics and β-lactamase inhibitors
Fan, P. F., Ma, Z., Partow, A. J., Kim, M., Shoemaker, G. M., Tan, R., Tong, Z., Nelson, C. D., Jang, Y., & Jeong, K. C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.035 · Cited by 28
Identification of Products of Inhibition of GES-2 β-Lactamase by Tazobactam by X-ray Crystallography and Spectrometry
Frase, H., Smith, C. A., Tóth, M., Champion, M. M., Mobashery, S., & Vakulenko, S. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208744 · Cited by 28
Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of l , d -Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC
Iannazzo, L., Soroka, D., Triboulet, S., Fonvielle, M., Compain, F., Dubée, V., Mainardi, J., Hugonnet, J., Braud, E., Arthur, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00096 · Cited by 28
Boronic acid inhibitors of the class A β-lactamase KPC-2
Zhou, J., Stapleton, P. D., Haider, S. M., & Healy, J. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.055 · Cited by 28
Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors
Li, J., Sun, L.-Y., Jiang, Z., Chen, C., Gao, H., Chigan, J., Ding, H., & Yang, K. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104576 · Cited by 28
Inhibition of a cold‐active alkaline phosphatase by imipenem revealed by in silico modeling of metallo‐β‐lactamase active sites
Chakraborty, S., Ásgeirsson, B., Minda, R., Salaye, L., Frère, J., & Rao, B. J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.08.030 · Cited by 27
Binding of (5S)-Penicilloic Acid to Penicillin Binding Protein 3
van Berkel, S. S., Nettleship, J. E., Leung, I. K. H., Brem, J., Choi, H., Stuart, D. I., Claridge, T. D. W., McDonough, M. A., Owens, R. J., Ren, J., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400200h · Cited by 27
A DNA nanoribbon as a potent inhibitor of metallo-β-lactamases
Ouyang, X., Chang, Y., Yang, K., Wang, W., Bai, J.-J., Wang, J., Zhang, Y., Wang, S., Xie, B.-B., & Wang, L. (2017) · Chemical Communications · doi:10.1039/c7cc04483f · Cited by 27
A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1)
Thomas, P. W., Cammarata, M. B., Brodbelt, J. S., Monzingo, A. F., Pratt, R. F., & Fast, W. L. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00393 · Cited by 27
Alerting prevalence of MBLs producing Pseudomonas aeruginosa isolates
Esmaeili, D., Daymad, S. F., Neshani, A., Rashki, S., Marzhoseyni, Z., & Khaledi, A. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100460 · Cited by 27
Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study
Allen, R. C., & Brown, S. P. (2019) · mBio · doi:10.1128/mbio.01831-19 · Cited by 26
Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem
Tehrani, K. H. M. E., Brüchle, N. C., Wade, N., Mashayekhi, V., Pesce, D., van Haren, M. J., & Martin, N. I. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00459 · Cited by 27
Recent advances in the development of β-lactamase inhibitors
Jalde, S. S., & Choi, H. K. (2020) · The Journal of Microbiology · doi:10.1007/s12275-020-0285-z · Cited by 27
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance
Wilson, B. M., Jiang, Y., Jump, R., Viau, R. A., Pérez, F., Bonomo, R. A., & Evans, S. R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1769 · Cited by 27
Self-citation
A plethora of carbapenem resistance inAcinetobacter baumannii: no end to a long insidious genetic journey
Vahhabi, A., Hasani, A., Rezaee, M. A., Baradaran, B., Hasani, A., Kafil, H. S., Abbaszadeh, F., & Dehghani, L. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1847421 · Cited by 30
Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy
Wong, J. C. Y., Au, E. Y. L., Yeung, H. H. F., Lau, C. S., & Li, P. H. (2021) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2021.13.2.284 · Cited by 27

Authors: Drawz, S. M., & Bonomo, R. A.
Affiliations: Departments of Pathology
United States Department of Veterans Affairs (US)
Corresponding author: Bonomo, Robert A.
ORCID: Bonomo, Robert A.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 160-201
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00037-09
PMC: PMC2806661
OpenAlex: W1895007034
Cited by: 1,709
References: 464
Citations by year: 2026: 83 · 2025: 100 · 2024: 87 · 2023: 86 · 2022: 106 · 2021: 126 · 2020: 151 · 2019: 130 · 2018: 131 · 2017: 119 · 2016: 120 · 2015: 108 · 2014: 93 · 2013: 88 · 2012: 81
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (1R01A1063517-01)
National Institute of General Medical Sciences (T32GM007250, T32GM07250)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords: beta-lactamase inhibitors, beta-lactamase, beta-lactam resistance, clavulanic acid, sulbactam, tazobactam, mechanism-based inactivators, carbapenemase inhibitors, extended-spectrum cephalosporin resistance, Enterobacteriaceae, penicillin-resistant staphylococci
MeSH terms: Bacteria, Bacterial Infections, Bacterial Proteins, beta-Lactamases, Enzyme Inhibitors, Humans, beta-Lactam Resistance, beta-Lactamase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Three Decades of β-Lactamase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks